Reduced number of CFTR molecules in erythrocyte plasma membrane of cystic fibrosis patients
- PMID: 16923725
- DOI: 10.1080/09687860600738304
Reduced number of CFTR molecules in erythrocyte plasma membrane of cystic fibrosis patients
Abstract
Cystic fibrosis (CF), the most common genetic disease among Caucasians, is caused by mutations in the gene encoding CFTR (cystic fibrosis transmembrane conductance regulator). The most frequent mutation, DeltaF508, results in protein misfolding and, as a consequence, prevents CFTR from reaching its final location at the cell surface. CFTR is expressed in various cell types including red blood cells. The functional role of CFTR in erythrocytes is still unclear. Since the number of CFTR copies in a single erythrocyte of healthy donors and CF patients with a homozygous DeltaF508 mutation is unknown, we counted CFTR, localized in erythrocyte plasma membrane, at the single molecule level. A novel experimental approach combining atomic force microscopy with quantum-dot-labeled anti-CFTR antibodies, used as topographic surface markers, was employed to detect individual CFTR molecules. Analysis of erythrocyte plasma membranes taken from healthy donors and CF patients with a homozygous DeltaF508 mutation reveals mean (SEM) values of 698 (12.8) (n=542) and 172 (3.8) (n=538) CFTR molecules per red blood cell, respectively. We conclude that erythrocytes reflect the CFTR status of the organism and that quantification of CFTR in a blood sample could be useful in the diagnosis of CFTR related diseases.
Similar articles
-
Expression of cystic fibrosis transmembrane conductance regulator in liver tissue from patients with cystic fibrosis.Hepatology. 2000 Aug;32(2):334-40. doi: 10.1053/jhep.2000.9111. Hepatology. 2000. PMID: 10915740
-
Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.J Cyst Fibros. 2008 Mar;7(2):102-9. doi: 10.1016/j.jcf.2007.06.001. Epub 2007 Jul 27. J Cyst Fibros. 2008. PMID: 17662673
-
Determination of CFTR densities in erythrocyte plasma membranes using recognition imaging.Nanotechnology. 2008 Sep 24;19(38):384017. doi: 10.1088/0957-4484/19/38/384017. Epub 2008 Aug 12. Nanotechnology. 2008. PMID: 21832576
-
Misfolding of the cystic fibrosis transmembrane conductance regulator and disease.Biochemistry. 2008 Feb 12;47(6):1465-73. doi: 10.1021/bi702209s. Epub 2008 Jan 15. Biochemistry. 2008. PMID: 18193900 Review.
-
[Functional characterization of naturally occurring CFTR mutants: interest for cystic fibrosis].Ann Biol Clin (Paris). 2006 Sep-Oct;64(5):429-37. Ann Biol Clin (Paris). 2006. PMID: 17040873 Review. French.
Cited by
-
Therapeutic CFTR Correction Normalizes Systemic and Lung-Specific S1P Level Alterations Associated with Heart Failure.Int J Mol Sci. 2022 Jan 14;23(2):866. doi: 10.3390/ijms23020866. Int J Mol Sci. 2022. PMID: 35055052 Free PMC article.
-
The Distribution and Role of the CFTR Protein in the Intracellular Compartments.Membranes (Basel). 2021 Oct 22;11(11):804. doi: 10.3390/membranes11110804. Membranes (Basel). 2021. PMID: 34832033 Free PMC article. Review.
-
Pharmacogenomics with red cells: a model to study protein variants of drug transporter genes.Vox Sang. 2021 Feb;116(2):141-154. doi: 10.1111/vox.12999. Epub 2020 Sep 30. Vox Sang. 2021. PMID: 32996603 Free PMC article. Review.
-
An Intriguing Involvement of Mitochondria in Cystic Fibrosis.J Clin Med. 2019 Nov 6;8(11):1890. doi: 10.3390/jcm8111890. J Clin Med. 2019. PMID: 31698802 Free PMC article. Review.
-
Cystic Fibrosis from Laboratory to Bedside: The Role of A20 in NF-κB-Mediated Inflammation.Med Princ Pract. 2015;24(4):301-10. doi: 10.1159/000381423. Epub 2015 Apr 25. Med Princ Pract. 2015. PMID: 25925366 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical